1128191-66-1

Basic information

• Product Name: N-[3-(1,5-dimethylimidazol-2-yl)-4-methyl-phenyl]-2-methyl-6-(trifluoromethyl)pyridine-3-carboxamide
• Synonyms: N-[3-(1,5-dimethylimidazol-2-yl)-4-methyl-phenyl]-2-methyl-6-(trifluoromethyl)pyridine-3-carboxamide
• CAS NO: 1128191-66-1
• Molecular Weight: 388.392
• Mol File: 1128191-66-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[3-(1,5-dimethylimidazol-2-yl)-4-methyl-phenyl]-2-methyl-6-(trifluoromethyl)pyridine-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-(1,5-dimethylimidazol-2-yl)-4-methyl-phenyl]-2-methyl-6-(trifluoromethyl)pyridine-3-carboxamide(1128191-66-1)
• EPA Substance Registry System: N-[3-(1,5-dimethylimidazol-2-yl)-4-methyl-phenyl]-2-methyl-6-(trifluoromethyl)pyridine-3-carboxamide(1128191-66-1)

Safety Data

• Hazardous Substances Data: 1128191-66-1(Hazardous Substances Data)

Upstream product

• 1128191-83-2 2-methyl-N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-6-(trifluoromethyl)nicotinamide 
• 235426-31-0 2-bromo-1,5-dimethyl-1H-imidazole 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF-975

The present disclosure relates to heterocyclic amide compounds, which are useful for inhibiting the Hedgehog pathway, and their use in treating a disease or medical condition mediated alone or in part by Hedgehog pathway inhibition. Also disclosed are methods for manufacture of these compounds, pharmaceutical compositions including these compounds, and use of these compounds in the manufacture of medicaments for treating such diseases and medical conditions in a subject.